Subdomain IB is the third major drug binding region of human serum albumin: toward the three-sites model.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Molecular Pharmaceutics

• Publication date

  2013-03-26

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/mp400027qPMID 23473402
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human serum albumin: from bench to bedside.

  2012cited by this paper
• Crystallographic analysis reveals the structural basis of the high-affinity binding of iophenoxic acid to human serum albumin

  2011cited by this paper
• Structural basis of binding of fluorescent, site-specific dansylated amino acids to human serum albumin

  2011cited by this paper
• Comparison of Binding Interactions of Lomefloxacin to Serum Albumin and Serum Transferrin by Resonance Light Scattering and Fluorescence Quenching Methods

  2011cited by this paper
• Aromatic side‐chain cluster of biotin binding site of avidin allows circular dichroism spectroscopic investigation of its ligand binding properties

  2011cited by this paper
• A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions.

  2010cited by this paper
• Crystallographic Survey of Albumin Drug Interaction and Preliminary Applications in Cancer Chemotherapy

  2010cited by this paper
• Crystallographic analysis reveals a unique lidocaine binding site on human serum albumin.

  2010cited by this paper
• Determination of human serum alpha1-acid glycoprotein and albumin binding of various marketed and preclinical kinase inhibitors.

  2009cited by this paper
• Lessons from the crystallographic analysis of small molecule binding to human serum albumin.

  2009cited by this paper
• Novel binding studies of human serum albumin with trans-feruloyl maslinic acid.

  2009cited by this paper
• Structural basis for the binding of naproxen to human serum albumin in the presence of fatty acids and the GA module.

  2008cited by this paper
• Crystallographic Analysis of Human Serum Albumin Complexed with 4Z,15E-Bilirubin-IXα

  2008cited by this paper
• A new drug binding subsite on human serum albumin and drug-drug interaction studied by X-ray crystallography.

  2008cited by this paper
• Interactions of human serum albumin with retinoic acid, retinal and retinyl acetate.

  2007cited by this paper
• Effect of human serum albumin on drug metabolism: structural evidence of esterase activity of human serum albumin.

  2007cited by this paper
• BMC Structural Biology BioMed Central

  2006cited by this paper
• Binding analysis of glycyrrhetinic acid to human serum albumin: fluorescence spectroscopy, FTIR, and molecular modeling.

  2006cited by this paper
• Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis.

  2006cited by this paper
• Interaction of daunomycin antibiotic with human serum albumin: investigation by resonant mirror biosensor technique, fluorescence spectroscopy and molecular modeling methods.

  2005cited by this paper
• Structural basis of the drug-binding specificity of human serum albumin.

  2005cited by this paper
• Allosteric modulation of monomeric proteins *

  2005cited by this paper
• Displacement of phenprocoumon (Marcumar®) from albumin by sulfonylurea compounds, suramin, and ioglycamic acid

  2004cited by this paper
• Probing the binding of the flavonoid, quercetin to human serum albumin by circular dichroism, electronic absorption spectroscopy and molecular modelling methods.

  2003cited by this paper
• Inhibition of drug binding to human serum albumin by cholecystographic agents.

  2003cited by this paper
• Predicting plasma protein binding of drugs: a new approach.

  2002cited by this paper
• The atomic structure of human methemalbumin at 1.9 A.

  2002cited by this paper
• Heme distortions in sperm-whale carbonmonoxy myoglobin: correlations between rotational strengths and heme distortions in MD-generated structures.

  2002cited by this paper
• Crystal Structure Analysis of Warfarin Binding to Human Serum Albumin

  2001cited by this paper
• Modulation of chromatographic performances of HSA-based HPLC column by reversible binding of lithocholic acid

  2001cited by this paper
• Induced chirality upon crocetin binding to human serum albumin: origin and nature

  2001cited by this paper
• Enantioselective inhibition of the binding of rac-profens to human serum albumin induced by lithocholate.

  2001cited by this paper
• Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin.

  2000cited by this paper
• Optical Activity and Stereochemistry of Linear Oligopyrroles and Bile Pigments

  1999cited by this paper
• Equilibrium binding of anthracycline cytostatics to serum albumin and small unilamellar phospholipid vesicles as measured by gel filtration.

  1998cited by this paper
• Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites

  1998cited by this paper
• Protein Binding in Plasma of Valsartan, a New Angiotensin II Receptor Antagonist

  1997cited by this paper
• Camptothecin‐binding site in human serum albumin and protein transformations induced by drug binding

  1997cited by this paper
• Interactions of lactone, carboxylate and self‐aggregated forms of camptothecin with human and bovine serum albumins

  1997cited by this paper
• Comparative serum protein binding of anthracycline derivatives

  1996cited by this paper
• Some aspect of the interactions of adriamycin with human serum albumin.

  1996cited by this paper
• Resolution of the Absorbance and CD Spectra and Formation Constants of the Complexes between Human Serum Albumin and Methyl Orange

  1996cited by this paper
• Characterization of binding site of uremic toxins on human serum albumin.

  1995cited by this paper
• Reduced albumin binding promotes the stability and activity of topotecan in human blood.

  1995cited by this paper
• In vitro study of the protein binding of fusidic acid: A contribution to the comprehension of its pharmacokinetic behaviour

  1995cited by this paper
• Differential interactions of camptothecin lactone and carboxylate forms with human blood components.

  1994cited by this paper
• Structure of serum albumin.

  1994cited by this paper
• The structural basis of camptothecin interactions with human serum albumin: impact on drug stability.

  1994cited by this paper
• Marked interspecies variations concerning the interactions of camptothecin with serum albumins: a frequency-domain fluorescence spectroscopic study.

  1994cited by this paper
• The structural characterization and bilirubin-binding properties of albumin Herborn, a [Lys240-->Glu] albumin mutant.

  1993cited by this paper
• Optical activity of hemoproteins in the Soret region. Circular dichroism of the heme undecapeptide of cytochrome c in aqueous solution.

  1993cited by this paper
• Identification of alpha-1-acid glycoprotein (orosomucoid) as a major vanilloid binding protein in serum.

  1992cited by this paper
• Conformation inversion of bilirubin formed by reduction of the biliverdin-human serum albumin complex: evidence from circular dichroism.

  1992cited by this paper
• Binding of vinca alkaloid analogues to human serum albumin and to alpha 1-acid glycoprotein.

  1991cited by this paper
• Binding of vinca alkaloid analogues to human serum albumin and to α1-acid glycoprotein

  1991cited by this paper
• Albumin protects against capsaicin- and adenosine-induced bronchoconstriction and reduces overflow of calcitonin gene-related peptide from guinea-pig lung.

  1990cited by this paper
• Location and characterization of the suramin binding sites of human serum albumin.

  1990cited by this paper
• Inhibition by capsaicin of NADH-quinone oxidoreductases is correlated with the presence of energy-coupling site 1 in various organisms.

  1990cited by this paper
• Binding of glycyrrhetinic acid to rat plasma, rat serum albumin, human serum, and human serum albumin.

  1988cited by this paper
• Fusidic Acid Binding to Serum Albumin and Interaction with Binding of Bilirubin

  1985cited by this paper
• Relations between high-affinity binding sites of markers for binding regions on human serum albumin.

  1985cited by this paper
• Hemin binding to serum proteins and the catalysis of interprotein transfer.

  1983cited by this paper
• Quantitative aspects of the interaction of bile acids with human serum albumin.

  1982cited by this paper
• Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.

  1982cited by this paper
• Competitive interaction of biliverdin and bilirubin only at the primary bilirubin binding site on human albumin.

  1981cited by this paper
• Molecular aspects of ligand binding to serum albumin.

  1981cited by this paper
• Investigations into the binding of phenprocoumon to albumin using fluorescence spectroscopy

  1980cited by this paper
• Kinetics and mechanism of the interaction between human serum albumin and monomeric haemin.

  1980cited by this paper
• Studies of the interaction of carbenoxolone sodium and warfarin sodiun in vivo [proceedings].

  1977cited by this paper
• Conjugated polyene fatty acids as fluorescent probes: binding to bovine serum albumin.

  1977cited by this paper
• Further characterization of specific drug binding sites on human serum albumin.

  1976cited by this paper
• Conformation of bilirubin and biliverdin in their complexes with serum albumin.

  1975cited by this paper
• Comparison of the human pharmacokinetics of VM-26 and VP-16, two antineoplastic epipodophyllotixin glucopyranoside derivatives.

  1975cited by this paper
• Optical acitvity of conjugated proteins

  1974cited by this paper
• Drug-protein binding: recent advances in methodology: spectroscopic techniques.

  1973cited by this paper
• RECENT ADVANCES IN METHODOLOGY: SPECTROSCOPIC TECHNIQUES

  1973cited by this paper
• QUANTITATIVE AND QUALITATIVE ASPECTS OF THE PLASMA PROTEIN BINDING OF CARBENOXOLONE, AN ULCER‐HEALING DRUG *

  1973cited by this paper
• Interaction of albumin and fusidic acid: Appendix on interaction of albumin and fusidic acid

  1971cited by this paper
• Interaction of albumin and fusidic acid.

  1971cited by this paper

• Dual anti-inflammatory and antidiabetic potential of ferrocenylmethylcyanophenyl derivatives: Integrated In Vitro and In Silico evaluation

  2026cites this paper
• Structure-driven design of albumin-based drug delivery systems.

  2026cites this paper
• Molecular analysis of the interaction and the unfolding behavior of porcine serum albumin with cationic biodegradable gemini surfactants

  2026cites this paper
• Comparative analysis of binding and quenching mechanisms of doxorubicin and ciprofloxacin with human serum albumin in ternary complexes

  2026cites this paper
• N-Heterocyclic Imine Derived Green Catalyst P2ML2 Shows Moderate Binding with Domain IB of Human Serum Albumin

  2026cites this paper
• Systematic development of quinolinium-based NIR probes for targeting subdomain IB region of human serum albumin

  2026cites this paper
• EFFICIENT AND SENSITIVE ANALYSIS OF BIOMOLECULAR INTERACTIONS BETWEEN PALBOCICLIB AND HUMAN SERUM ALBUMIN USING FLUORESCENCE QUENCHING MECHANISM

  2026cites this paper
• Phenanthrene Alkaloids From Guatteria Olivacea as Topoisomerase II Inhibitors: Theoretical Insights and Cytotoxic Evaluation

  2026cites this paper
• Protein-based nanocarriers in the management of hard-to-treat solid tumours.

  2026cites this paper
• Biophysical aspects of 3-Hydroxychromone-based uracil's interaction with the serum protein

  2026cites this paper
• Multitarget evaluation of 4-substituted 7-hydroxycoumarin derivatives: anticancer activity, topoisomerase I inhibition, and interaction with human serum albumin.

  2026cites this paper
• Copra meal and guar gum β-manno-oligosaccharides inhibit glycation of human serum albumin: Mechanistic insights using multi-spectroscopic and bioinformatic analysis.

  2025cites this paper
• Molecular interaction of abemaciclib with human serum albumin: Insights from spectroscopy, microscopy, and computational approaches.

  2025cites this paper
• Trimetazidine–Profen Hybrid Molecules: Synthesis, Chemical Characterization, and Biological Evaluation of Their Racemates

  2025cites this paper
• Albumin: Bountiful Arrow in the Quiver of Liver and Its Significance in Physiology

  2025cites this paper
• Binding interactions between ar-turmerone and human serum albumin: mechanistic and biophysical insights.

  2025cites this paper
• Exploring the binding interaction of 1,4-naphthoquinone derivative–human serum albumin complex by biophysics and molecular simulation

  2025cites this paper
• Elucidating the binding mechanism between macluraxanthone and bovine serum albumin: multi-spectroscopic, computational, and biological insights.

  2025cites this paper
• Chemical Insights into Oligonucleotide-Protein Binding for Therapeutic Applications.

  2025cites this paper
• Exploring Pitolisant Binding to Human Serum Albumin: Insights from Multi-Spectroscopic, Molecular Docking and Molecular Dynamics Studies

  2025cites this paper
• Selective Recognition of Oncogene Promoter C-Myc G-Quadruplex: Design, Synthesis, and In Vitro Evaluation of Naphthalimide and Imidazo[1,2-a]pyrazines for Their Anticancer Activity.

  2025cites this paper
• Molecular dynamics analysis of hyaluronic acid-albumin complexes: effect of the HSA-to-HA ratio on structure and stability.

  2025cites this paper
• Drug-biomolecular interaction: Spectroscopic and computational insights into esomeprazole binding with human serum albumin.

  2025cites this paper
• Serum albumin nanoparticles: Ligand functionalization for enhanced targeted therapeutics in precision medicine

  2025cites this paper
• Esterase Profile: Structural, Functional and Evolutionary Aspects of Human and Animal Blood Esterases

  2025cites this paper
• Docking and Molecular Dynamics Simulations of Polyligand Complexes of Aspirin with Human Serum Albumin

  2025cites this paper
• Improved albumin binding properties of Isoguvacine upon esterification as characterized by biophysical and computational tools

  2025influential citation
• Comprehensive characterization of the interaction between prototypical drug-site markers and multiple sites on human serum albumin by microbore frontal gel chromatography.

  2025cites this paper
• Complex Investigation of the Similarities and Differences between Ten Commercially Available Human Serum Albumin Preparations

  2025cites this paper
• Nickel(II) complex of p-tolylglyoxime: structural investigations, ADMET predictions, in-silico DNA and HSA binding assessments

  2025cites this paper
• Novel Sulfonamide‐Sydnone Hybrids: Complementary Insight into Anti‐Inflammatory Action, Anti‐SARS‐CoV‐2 Activity, Human Serum Albumin Interaction, and in silico Analysis

  2025cites this paper
• The Molecular Recognition of Lurasidone by Human Serum Albumin: A Combined Experimental and Computational Approach

  2025cites this paper
• Broad-spectrum anticancer properties, DFT calculations and macromolecular binding potential of a novel thiolato-bridged fac-Mn(CO)3-core-based CO-releasing molecule.

  2025cites this paper
• Assessing the molecular interaction between a COVID-19 drug, nirmatrelvir, and human serum albumin: calorimetric, spectroscopic, and microscopic investigations

  2025cites this paper
• Albumin-mediated binding mechanisms of crocin-1 and crocetin: thermodynamics, molecular dynamics, and implications for warfarin displacement

  2025cites this paper
• Molecular interaction study of flavonols with human serum albumin by theoretical simulations.

  2025cites this paper
• Assessing Modes of Toxic Action of Organic Cations in In Vitro Cell-Based Bioassays: the Critical Role of Partitioning to Cells and Medium Components

  2025cites this paper
• Exploring (alkyl-ω-ol)triphenyltin(IV) compounds as renin inhibitors: Structural insights, binding dynamics, and pharmacokinetic profiling for antihypertensive therapy

  2025cites this paper
• Near-infrared light activatable nanoplatform for proteins labeling, enrichment and visualization in living systems

  2025cites this paper
• Fabrication of poly(malachite green)/Nafion@Nanotubes modified sensor for sensitive analysis of gallic acid and computational-electrochemical approaches on its interaction with human serum albumin

  2025cites this paper
• Enhanced Binding Site Identification in Protein-Ligand Complexes with a Combined Blind Docking and Dipolar Electron Paramagnetic Resonance Approach.

  2025cites this paper
• Small-Molecule Fe3+-Based Magnetic Resonance Imaging Probe Enables Noninvasive Imaging of Pancreatic Zn2+ and β-Cell Function In Vivo.

  2025cites this paper
• Comprehensive insights into the binding interaction studies of Serum albumins with Contaminants of Emerging Concern Turning the page from 2010-2023

  2025cites this paper
• Albumin Is an Integrative Protein of Blood Plasma and Beyond

  2024cites this paper
• The effects of aspirin acetylation of human serum albumin on its interactions with methotrexate

  2024cites this paper
• Role for Carboxylic Acid Moiety in NSAIDs: Favoring the Binding at Site II of Bovine Serum Albumin.

  2024cites this paper
• Molecular displacement approach for the electrochemical detection of protein-bound propofol

  2024cites this paper
• Investigation of the interaction between S-isoalkyl derivatives of the thiosalicylic acid and human serum albumin

  2024cites this paper
• A fast and responsive turn-on fluorescent probe based on a quinone conjugated alkoxy derivative for biothiols and a cellular imaging study

  2024cites this paper
• Effects of Chrysin and Chrysin-7-sulfate on Ochratoxin A-Albumin Interactions and on the Plasma and Kidney Levels of the Mycotoxin in Rats

  2024cites this paper
• Binding characteristics of the major kratom alkaloid, mitragynine, towards serum albumin: spectroscopic, calorimetric, microscopic, and computational investigations.

  2024cites this paper
• Multifaceted Analysis of Bempedoic Acid Binding to Subdomain IIA of Human Serum Albumin

  2024cites this paper
• Ligand binding to proteins - when flawed fluorescence quenching methodology and interpretation become the new norm.

  2024cites this paper
• Generation of affinity maps for thiazolidinediones with human serum albumin using affinity microcolumns. II. Effects of advanced glycation end products on multisite drug binding.

  2024cites this paper
• Modulation of Albumin Esterase Activity by Warfarin and Diazepam

  2024cites this paper
• Lapachol, a natural food component, interacts with human serum albumin: Insights of its impact on the pharmacokinetics of clinically used drugs.

  2024cites this paper
• The Neoteric Paradigm of Biomolecule-Functionalized Albumin-Based Targeted Cancer Therapeutics

  2024cites this paper
• Synthesis of Novel Benzothiazole–Profen Hybrid Amides as Potential NSAID Candidates

  2024cites this paper
• Thermal effects and drugs competition on the palmitate binding capacity of human serum albumin.

  2024cites this paper
• Modulation of the photobehavior of gefitinib and its phenolic metabolites by human transport proteins

  2024cites this paper
• Interaction of Cephalosporins with Human Serum Albumin: A Structural Study.

  2024cites this paper
• Structural and mechanistic insights into the transport of aristolochic acids and their active metabolites by human serum albumin

  2024cites this paper
• Computational Study of Molecular Mechanism for the Involvement of Human Serum Albumin in the Renin–Angiotensin–Aldosterone System

  2024cites this paper
• Investigating the Serum Albumin Binding Behavior of Naphthalimide Based Fluorophore Conjugates: Spectroscopic and Molecular Docking Approach

  2024cites this paper
• A fluorescent "Turn-ON" probe with rapid and differential response to HSA and BSA: quantitative detection of HSA in urine.

  2024cites this paper
• In Search for Low-Molecular-Weight Ligands of Human Serum Albumin That Affect Its Affinity for Monomeric Amyloid β Peptide

  2024cites this paper
• Bisphenol a modification and how its structure influences human serum albumin binding force

  2024cites this paper
• Search for new biologically active compounds: in vitro studies of antitumor and antimicrobial activity of dirhodium(II,II) paddlewheel complexes.

  2024cites this paper
• New Ru(II)-p-cymene compounds bearing indomethacin and indomethacin-pyridineamide ligands: Synthesis, characterization, computational studies and investigation of their interactions with the human serum albumin

  2024cites this paper
• Invitro anti-biofilm activity and the artificial chaperone activity of quinoline-based ionic liquids.

  2024cites this paper
• Molecular Basis for the Involvement of Mammalian Serum Albumin in the AGE/RAGE Axis: A Comprehensive Computational Study

  2024cites this paper
• Profiling the Interaction between Human Serum Albumin and Clinically Relevant HIV Reverse Transcriptase Inhibitors

  2024cites this paper
• Generation of affinity maps for thiazolidinediones with human serum albumin using affinity microcolumns. I. Studies of effects by glycation on multisite drug binding.

  2024cites this paper
• Enhancing the hydrophilicity of poly(lactic-co-glycolic acid) with serum albumin by creating colloidal drug carriers

  2024cites this paper
• Copper(ii) complexes of sterically hindered phenolic Schiff bases: synthesis, characterization, interaction with biomolecules, and antioxidant and antimicrobial activity

  2024cites this paper
• A mini review on human serum albumin - natural alkaloids interaction and its role as drug carrier

  2024cites this paper
• Biomolecular interaction of pretomanid and its pro-liposomal formulation with human serum albumin by multi-spectroscopic, surface plasmon resonance and molecular docking approaches

  2024cites this paper
• A novel albumin-binding macrocyclic Gd-HPDO3A complex bearing a deoxycholic acid residue: the role of the hydration state, water exchange and local dynamics in the observed relaxivity

  2024cites this paper
• Factors Affecting the Synthesis of Bovine Serum Albumin Nanoparticles Using the Desolvation Method

  2024cites this paper
• Seeking for Innovation with Magnetic Resonance Imaging Paramagnetic Contrast Agents: Relaxation Enhancement via Weak and Dynamic Electrostatic Interactions with Positively Charged Groups on Endogenous Macromolecules

  2023cites this paper
• HSA-ZW800-PEG for Enhanced Optophysical Stability and Tumor Targeting

  2023cites this paper
• Comparison of Tumor Binding Across Tumor Types and Cell Lines to Support Free Drug Considerations for Oncology Drug Discovery.

  2023cites this paper
• Modification of gradient HPLC method for determination of small molecules' affinity to human serum albumin under column safety conditions: Robustness and chemometrics study.

  2023cites this paper
• Photophysical, rotational and translational properties of Radachlorin photosensitizer upon binding to serum albumins.

  2023cites this paper
• Multi-Cavity Molecular Descriptor Interconnections: Enhanced Protocol for Prediction of Serum Albumin Drug Binding.

  2023cites this paper
• In vitro biodistribution studies on clinically approved FGFR inhibitors ponatinib, nintedanib, erlotinib and an investigational inhibitor KP2692.

  2023cites this paper
• Alcohol-induced retarded protein dynamics of human serum albumin unveiled by temperature jump

  2023cites this paper
• Exploring Benzene Ru(II) Complexes of 2-Subsitituted Quinoline/Napthyridine Ligands: Synthesis, Biomacromolecular Binding and DFT Investigations

  2023cites this paper
• DFT, ADME studies and evaluation of the binding with HSA and MAO-B inhibitory potential of protoberberine alkaloids from Guatteria friesiana: theoretical insights of promising candidates for the treatment of Parkinson’s disease

  2023cites this paper
• HPLC Analysis and In Vitro and In Silico Evaluation of the Biological Activity of Polyphenolic Components Separated with Solvents of Various Polarities from Helichrysum italicum

  2023cites this paper
• Targeted Near-Infrared Fluorescence Imaging of Liver Cancer using Dual-Peptide-Functionalized Albumin Particles

  2023cites this paper
• Interaction mechanism of a cysteine protease inhibitor, odanacatib, with human serum albumin: In vitro and bioinformatics studies.

  2023cites this paper
• Unraveling the versatility of human serum albumin – A comprehensive review of its biological significance and therapeutic potential

  2023cites this paper
• Orthogonally Engineered Albumin with Attenuated Macrophage Phagocytosis for the Targeted Visualization and Phototherapy of Liver Cancer.

  2023cites this paper
• Biophysical and docking study on the interaction of anticancer drugs encorafenib and binimetinib with human serum albumin.

  2023cites this paper
• Synthesis, Crystal Structure, Hirshfeld Surface Analysis, DNA/BSA Interaction and Molecular Docking Studies of 2-(6-(4-chlorophenyl)-1,2,4-triazin-3-yl)quinoline

  2023cites this paper
• Noncovalent Association Thermodynamics of Turn‐On Fluorescent Probes with Human Serum Albumin: Dual‐Concentration Ratio Method

  2023cites this paper
• Human serum albumin subdomain IB is physiologically adapted for payloading homopterocarpin to human aldehyde dehydrogenase: Combinatorial in vitro and in silico approaches

  2023cites this paper
• Probing the potential toxicity of trimetazidine by characterizing its interaction with human serum albumin

  2023cites this paper
• A Comprehensive Study on the Binding of Anti-cancer Drug (Floxuridine) with Human Serum Albumin

  2023cites this paper